Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma : a meta-analysis of observational studies
BACKGROUND: The influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma (HCC) remains a matter of debate. This study is a meta-analysis of the available evidence.
METHODS: A literature search was performed to identify comparative studies reporting postoperative survival of HCC in different types of viral hepatitis. Pooled odds ratios (OR) and weighted mean differences (WMD with 95% confidence intervals (95% CI) were calculated using either the fixed effects model or random effects model.
RESULTS: Twenty studies matched the selection criteria and reported on 4744 subjects, of whom 2008 in the HBV-positive (B-HCC) group, 2222 in the HCV-positive (C-HCC) group, and 514 in the hepatitis B- and C-negative (NBNC-HCC). Meta-analysis showed that patients with HBV or HCV infection had a worse 5-year disease-free survival when compared to patients with NBNC-HCC (respectively: OR: 0.39, 95% CI: 0.28 to 0.53, P < 0.001; WMD: 0.37, 95% CI: 0.22 to 0.64, P < 0.001). There was a tendency toward higher 5-year overall survival rates in the NBNC-HCC group compared to those in the other two groups, although these differences were not statistically significant. Both the 5-year overall survival and disease-free survival were not different among the B-HCC and C-HCC groups.
CONCLUSIONS: Patients with positive serology for hepatitis B or C undergoing resection for HCC had a poor prognosis compared to patients with negative serology.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2011 |
---|---|
Erschienen: |
2011 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
World journal of surgical oncology - 9(2011) vom: 21. Sept., Seite 108 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhou, Yanming [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 03.01.2012 Date Revised 20.10.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/1477-7819-9-108 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM211618497 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM211618497 | ||
003 | DE-627 | ||
005 | 20231224013923.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2011 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/1477-7819-9-108 |2 doi | |
028 | 5 | 2 | |a pubmed24n0705.xml |
035 | |a (DE-627)NLM211618497 | ||
035 | |a (NLM)21933440 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhou, Yanming |e verfasserin |4 aut | |
245 | 1 | 0 | |a Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma |b a meta-analysis of observational studies |
264 | 1 | |c 2011 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.01.2012 | ||
500 | |a Date Revised 20.10.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: The influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma (HCC) remains a matter of debate. This study is a meta-analysis of the available evidence | ||
520 | |a METHODS: A literature search was performed to identify comparative studies reporting postoperative survival of HCC in different types of viral hepatitis. Pooled odds ratios (OR) and weighted mean differences (WMD with 95% confidence intervals (95% CI) were calculated using either the fixed effects model or random effects model | ||
520 | |a RESULTS: Twenty studies matched the selection criteria and reported on 4744 subjects, of whom 2008 in the HBV-positive (B-HCC) group, 2222 in the HCV-positive (C-HCC) group, and 514 in the hepatitis B- and C-negative (NBNC-HCC). Meta-analysis showed that patients with HBV or HCV infection had a worse 5-year disease-free survival when compared to patients with NBNC-HCC (respectively: OR: 0.39, 95% CI: 0.28 to 0.53, P < 0.001; WMD: 0.37, 95% CI: 0.22 to 0.64, P < 0.001). There was a tendency toward higher 5-year overall survival rates in the NBNC-HCC group compared to those in the other two groups, although these differences were not statistically significant. Both the 5-year overall survival and disease-free survival were not different among the B-HCC and C-HCC groups | ||
520 | |a CONCLUSIONS: Patients with positive serology for hepatitis B or C undergoing resection for HCC had a poor prognosis compared to patients with negative serology | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Review | |
700 | 1 | |a Si, Xiaoying |e verfasserin |4 aut | |
700 | 1 | |a Wu, Lupeng |e verfasserin |4 aut | |
700 | 1 | |a Su, Xu |e verfasserin |4 aut | |
700 | 1 | |a Li, Bin |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Zhiming |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t World journal of surgical oncology |d 2003 |g 9(2011) vom: 21. Sept., Seite 108 |w (DE-627)NLM125391404 |x 1477-7819 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2011 |g day:21 |g month:09 |g pages:108 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/1477-7819-9-108 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2011 |b 21 |c 09 |h 108 |